Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.

INTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR surveillance have been limited to ART-naïve populations....

Full description

Bibliographic Details
Main Authors: Guoqing Zhang, Joshua DeVos, Sandra Medina-Moreno, Nicholas Wagar, Karidia Diallo, R Suzanne Beard, Du-Ping Zheng, Christine Mwachari, Carolyn Riwa, Boniface Jullu, Ngugi Evelyn Wangari, Mary S Kibona, Lucy W Ng'Ang'A, Elliot Raizes, Chunfu Yang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6128523?pdf=render
_version_ 1819262444211535872
author Guoqing Zhang
Joshua DeVos
Sandra Medina-Moreno
Nicholas Wagar
Karidia Diallo
R Suzanne Beard
Du-Ping Zheng
Christine Mwachari
Carolyn Riwa
Boniface Jullu
Ngugi Evelyn Wangari
Mary S Kibona
Lucy W Ng'Ang'A
Elliot Raizes
Chunfu Yang
author_facet Guoqing Zhang
Joshua DeVos
Sandra Medina-Moreno
Nicholas Wagar
Karidia Diallo
R Suzanne Beard
Du-Ping Zheng
Christine Mwachari
Carolyn Riwa
Boniface Jullu
Ngugi Evelyn Wangari
Mary S Kibona
Lucy W Ng'Ang'A
Elliot Raizes
Chunfu Yang
author_sort Guoqing Zhang
collection DOAJ
description INTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR surveillance have been limited to ART-naïve populations. To investigate if DBS under certain conditions may also be a feasible sample type for HIVDR testing in ART patients, we piloted nationwide surveys for HIVDR among ART patients using DBS in two African countries with rapid scale-up of ART. METHODS:EDTA-venous blood was collected to prepare DBS from adult and pediatric ART patients receiving treatment during the previous 12-36 months. DBS were stored at ambient temperature for two weeks and then at -80°C until shipment at ambient temperature to the WHO-designated Specialized HIVDR Laboratory at CDC in Atlanta. Viral load (VL) was determined using NucliSENS EasyQ® HIV-1 v2.0 kits; HIVDR genotyping was performed using the ATCC HIV-1 Drug Resistance Genotyping kits. RESULTS:DBS were collected from 1,368 and 1,202 ART patients; 244 and 255 these specimens had VL ≥1,000 copies/mL in Kenya and Tanzania, respectively. The overall genotyping rate of those DBS with VL ≥1,000 copies/mL was 93.0% (95% CI: 89.1%-95.6%) in Kenya and 91.8% (87.7%-94.6%) in Tanzania. The turnaround times for the HIVDR surveys from the time of collecting DBS to completing laboratory testing were 6.5 months and 9.3 months for the Kenya and Tanzania surveys, respectively. CONCLUSIONS:The study demonstrates a favorable outcome of using DBS for nationwide surveillance of HIVDR in ART patients. Our results confirm that DBS collected and stored at ambient temperature for two weeks, and shipped with routine courier services are a reliable sample type for large-scale surveillance of acquired HIVDR.
first_indexed 2024-12-23T19:57:47Z
format Article
id doaj.art-01486e7b61ca4fc58e10e95bf3b404a7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:57:47Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-01486e7b61ca4fc58e10e95bf3b404a72022-12-21T17:33:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01139e020329610.1371/journal.pone.0203296Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.Guoqing ZhangJoshua DeVosSandra Medina-MorenoNicholas WagarKaridia DialloR Suzanne BeardDu-Ping ZhengChristine MwachariCarolyn RiwaBoniface JulluNgugi Evelyn WangariMary S KibonaLucy W Ng'Ang'AElliot RaizesChunfu YangINTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR surveillance have been limited to ART-naïve populations. To investigate if DBS under certain conditions may also be a feasible sample type for HIVDR testing in ART patients, we piloted nationwide surveys for HIVDR among ART patients using DBS in two African countries with rapid scale-up of ART. METHODS:EDTA-venous blood was collected to prepare DBS from adult and pediatric ART patients receiving treatment during the previous 12-36 months. DBS were stored at ambient temperature for two weeks and then at -80°C until shipment at ambient temperature to the WHO-designated Specialized HIVDR Laboratory at CDC in Atlanta. Viral load (VL) was determined using NucliSENS EasyQ® HIV-1 v2.0 kits; HIVDR genotyping was performed using the ATCC HIV-1 Drug Resistance Genotyping kits. RESULTS:DBS were collected from 1,368 and 1,202 ART patients; 244 and 255 these specimens had VL ≥1,000 copies/mL in Kenya and Tanzania, respectively. The overall genotyping rate of those DBS with VL ≥1,000 copies/mL was 93.0% (95% CI: 89.1%-95.6%) in Kenya and 91.8% (87.7%-94.6%) in Tanzania. The turnaround times for the HIVDR surveys from the time of collecting DBS to completing laboratory testing were 6.5 months and 9.3 months for the Kenya and Tanzania surveys, respectively. CONCLUSIONS:The study demonstrates a favorable outcome of using DBS for nationwide surveillance of HIVDR in ART patients. Our results confirm that DBS collected and stored at ambient temperature for two weeks, and shipped with routine courier services are a reliable sample type for large-scale surveillance of acquired HIVDR.http://europepmc.org/articles/PMC6128523?pdf=render
spellingShingle Guoqing Zhang
Joshua DeVos
Sandra Medina-Moreno
Nicholas Wagar
Karidia Diallo
R Suzanne Beard
Du-Ping Zheng
Christine Mwachari
Carolyn Riwa
Boniface Jullu
Ngugi Evelyn Wangari
Mary S Kibona
Lucy W Ng'Ang'A
Elliot Raizes
Chunfu Yang
Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
PLoS ONE
title Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
title_full Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
title_fullStr Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
title_full_unstemmed Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
title_short Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
title_sort utilization of dried blood spot specimens can expedite nationwide surveillance of hiv drug resistance in resource limited settings
url http://europepmc.org/articles/PMC6128523?pdf=render
work_keys_str_mv AT guoqingzhang utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT joshuadevos utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT sandramedinamoreno utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT nicholaswagar utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT karidiadiallo utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT rsuzannebeard utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT dupingzheng utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT christinemwachari utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT carolynriwa utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT bonifacejullu utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT ngugievelynwangari utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT maryskibona utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT lucywnganga utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT elliotraizes utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings
AT chunfuyang utilizationofdriedbloodspotspecimenscanexpeditenationwidesurveillanceofhivdrugresistanceinresourcelimitedsettings